The SOD1-G93A (glycine 93 to alanine) mutation is a comparatively rare ALS mutation in humans, but it is the most studied and published mutation within experimental transgenic ALS mouse models (2,3). Here, SOD1 is linked to amyotrophic lateral sclerosis.